Novo Nordisk Aktie
42,79
EUR
+0,70
EUR
+1,65
%
42,72
EUR
+1,43
EUR
+3,46
%
Werbung
Novo Nordisk Aktie Analyse
| 03.02.17 | Novo Nordisk buy | UBS AG | |
| 03.02.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 03.02.17 | Novo Nordisk Neutral | Citigroup Corp. | |
| 03.02.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 30.01.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 27.01.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 24.01.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 24.01.17 | Novo Nordisk Hold | Commerzbank AG | |
|
Werbung
|
|||
| 23.01.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 23.01.17 | Novo Nordisk Hold | Kepler Cheuvreux | |
| 23.01.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 19.01.17 | Novo Nordisk buy | UBS AG | |
| 09.01.17 | Novo Nordisk buy | Deutsche Bank AG | |
| 03.01.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 19.12.16 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 16.12.16 | Novo Nordisk Hold | HSBC | |
| 06.12.16 | Novo Nordisk buy | UBS AG | |
| 30.11.16 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 30.11.16 | Novo Nordisk Neutral | Citigroup Corp. | |
| 30.11.16 | Novo Nordisk buy | Deutsche Bank AG | |
| 30.11.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 21.11.16 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 07.11.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 07.11.16 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 04.11.16 | Novo Nordisk Equal-Weight | Morgan Stanley | |
| 03.11.16 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 01.11.16 | Novo Nordisk Hold | Kepler Cheuvreux | |
| 01.11.16 | Novo Nordisk buy | Deutsche Bank AG | |
| 01.11.16 | Novo Nordisk Neutral | Citigroup Corp. | |
| 31.10.16 | Novo Nordisk Neutral | Citigroup Corp. | |
| 31.10.16 | Novo Nordisk Sell | Société Générale Group S.A. (SG) | |
| 31.10.16 | Novo Nordisk Equal-Weight | Morgan Stanley | |
| 31.10.16 | Novo Nordisk Hold | HSBC | |
| 31.10.16 | Novo Nordisk Neutral | Credit Suisse Group | |
| 31.10.16 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 31.10.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 28.10.16 | Novo Nordisk Hold | S&P Capital IQ | |
| 27.10.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 14.10.16 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 13.10.16 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 30.09.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 19.09.16 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 16.09.16 | Novo Nordisk buy | Citigroup Corp. | |
| 14.09.16 | Novo Nordisk Outperform | BNP PARIBAS | |
| 13.09.16 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 09.09.16 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 08.09.16 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 05.09.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 02.09.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 02.09.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
Werbung
Werbung